Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Urol. 2021 Aug 26:101097JU0000000000002182. doi: 10.1097/JU.0000000000002182

Table 3:

Characteristics among patients with lesions undetected by MRI-targeted

N Missed by Radiologist n = 3 Missed on Targeting n = 21 MRI-Invisible n = 17
Age 41 71.0 (68.0–73.5) 65.0 (58.0–71.0) 65.0 (59.0–68.0)
Race 41
 White 3 (100%) 16 (76%) 9 (53%)
 Black 0 (0%) 4 (19%) 7 (41%)
 Asian 0 (0%) 0 (0%) 1 (5.9%)
 Other 0 (0%) 1 (4.8%) 0 (0%)
Prior Bx Hx 41
 Naive 1 (33%) 3 (14%) 3 (18%)
 Negative 1 (33%) 7 (33%) 5 (29%)
 Positive 1 (33%) 11 (52%) 9 (53%)
PSA 41 7.2 (5.7–10.2) 7.8 (5.3–11.6) 8.0 (4.9–11.9)
DRE Clinical Stage 41
 NA 0 (0%) 1 (4.8%) 1 (5.9%)
 T1c 3 (100%) 20 (95%) 15 (88%)
 T2a 0 (0%) 0 (0%) 1 (5.9%)
MRI volume (ml) 41 49.0 (43.5–56.9) 50.0 (40.0–59.0) 55.0 (46.0–66.0)
# of targets 41 2.0 (1.5–3.5) 2.0 (1.0–3.0) 3.0 (2.0–4.0)
# of cores on targeted Bx 41 4.0 (3.0–7.0) 4.0 (2.0–6.0) 6.0 (4.0–8.0)
# positive cores on targeted Bx 41 1.0 (0.5–3.0) 2.0 (1.0–3.0) 2.0 (0.0–2.0)
# of Random cores 41 12.0 (12.0–12.0) 12.0 (12.0–12.0) 12.0 (12.0–12.0)
# positive Random cores 41 4.0 (3.0–6.0) 3.0 (2.0–5.0) 2.0 (1.0–5.0)
PI-RADS of visible MRI index lesion 41
2 0 (0%) 0 (0%) 2 (12%)
3 1 (33%) 1 (4.8%) 3 (18%)
4 1 (33%) 12 (57%) 9 (53%)
5 1 (33%) 8 (38%) 3 (18%)
Size of MRI index lesion (cm) 41 1.2 (1.1–1.4) 1.1 (0.9–1.8) 1.0 (0.8–1.2)
Size of missed lesion (cm) 24 0.6 (0.6–0.9) 1.1 (0.9–1.3)
Location of missed lesion 24
Zone Peripheral 2 (67%) 18 (86%)
Transition 1 (33) 3 (14%)
Apex-Base Apical 2 (67%) 6 (29%)
Apical-mid 0 5 (24%)
Base 0 1 (4.8%)
Mid 1 (33%) 5 (24%)
Mid-base 0 4 (19%)
Laterality Left 2 (67%) 7 (33%)
Midline 0 3 (14%)
Right 1 (33%) 11 (52%)
Anterior-Posterior Anterior 1 (33%) 6 (29%)
Posterior 2 (67%) 15 (71%)
1.

Statistics presented: Median (25%–75%); n (%)